74 related articles for article (PubMed ID: 16818)
1. Suppression of ACTH secretion by synthetic MSH-release inhibiting factor Pro-Leu-Gly-NH2 in Addison's disease.
Voigt KH; Fehm HL; Lang RE; Beinert KE; Pfeiffer EF
Horm Metab Res; 1977 Mar; 9(2):150-2. PubMed ID: 16818
[TBL] [Abstract][Full Text] [Related]
2. Synthetic MIF has no effect on beta-MSH and ACTH hypersecretion in Nelson's syndrome.
Donnadieu M; Laurent MF; Luton JP; Bricaire H; Girard F; Binoux M
J Clin Endocrinol Metab; 1976 Jun; 42(6):1145-8. PubMed ID: 6486
[TBL] [Abstract][Full Text] [Related]
3. Normal and abnormal regulation of beta-msh in man.
Abe K; Nicholson WE; Liddle GW; Orth DN; Island DP
J Clin Invest; 1969 Aug; 48(8):1580-5. PubMed ID: 4307702
[TBL] [Abstract][Full Text] [Related]
4. New evidence that demonstrates that L-pro-L-leu-L-gly-NH2 might be the natural MIF.
Vivas A; Celis ME
Acta Physiol Lat Am; 1977; 27(4):177-82. PubMed ID: 31762
[TBL] [Abstract][Full Text] [Related]
5. Effect of prolonged administration of CRF on plasma concentrations of ACTH in patients with Addison's disease.
Pirich K; Vierhapper H; Nowotny P; Waldhäusl W
Exp Clin Endocrinol; 1986 Jul; 87(2):208-10. PubMed ID: 3019743
[TBL] [Abstract][Full Text] [Related]
6. Structure activity relationship studies with hypothalamic peptide hormones. I. Effect of melanotropin release inhibiting factor and analogs on tolerance to morphine in the rat.
Bhargava HN; Kim HS
J Pharmacol Exp Ther; 1982 Feb; 220(2):394-8. PubMed ID: 6120229
[TBL] [Abstract][Full Text] [Related]
7. Plasma galanin, vasopressin, and oxytocin in patients with Addison's disease.
Grenbäck E; Hulting AL; Bucht E; Petersson M
Horm Metab Res; 2007 Aug; 39(8):589-95. PubMed ID: 17712724
[TBL] [Abstract][Full Text] [Related]
8. Effect of Tyr-MIF-1 peptides on blood ACTH and corticosterone concentration induced by three experimental models of stress.
Bocheva A; Dzambazova E; Hadjiolova R; Traikov L; Mincheva R; Bivolarski I
Auton Autacoid Pharmacol; 2008 Oct; 28(4):117-23. PubMed ID: 18798907
[TBL] [Abstract][Full Text] [Related]
9. Positive rate-sensitive corticosteroid feedback mechanism of ACTH secretion in Cushing's disease.
Fehm HL; Voigt KH; Kummer G; Pfeiffer EF
J Clin Invest; 1979 Jul; 64(1):102-8. PubMed ID: 221540
[TBL] [Abstract][Full Text] [Related]
10. The effect of low-dose naloxone infusion on plasma ACTH and LH in patients with Cushing's and Addison's diseases.
Moreira AC; Foss MC; Iazigi N; Verissimo JM
Horm Metab Res; 1988 Apr; 20(4):230-4. PubMed ID: 2840381
[TBL] [Abstract][Full Text] [Related]
11. Loperamide modifies but does not block the corticotropin-releasing hormone-induced ACTH response in patients with Addison's disease.
Ambrosi B; Bochicchio D; Colombo P; Ferrario R; Faglia G
Horm Metab Res Suppl; 1987; 16():74-5. PubMed ID: 2832297
[TBL] [Abstract][Full Text] [Related]
12. Pituitary proopiomelanocortin-derived peptides and hypothalamus-pituitary-interrenal axis activity in gilthead sea bream (Sparus aurata) during prolonged crowding stress: differential regulation of adrenocorticotropin hormone and alpha-melanocyte-stimulating hormone release by corticotropin-releasing hormone and thyrotropin-releasing hormone.
Rotllant J; Balm PH; Ruane NM; Pérez-Sánchez J; Wendelaar-Bonga SE; Tort L
Gen Comp Endocrinol; 2000 Aug; 119(2):152-63. PubMed ID: 10936035
[TBL] [Abstract][Full Text] [Related]
13. Possible aminergic mediation of MSH release and of the CNS effects of MSH and MIF-I.
Kastin AJ; Schally AV; Kostrzewa RM
Fed Proc; 1980 Sep; 39(11):2931-6. PubMed ID: 6105977
[TBL] [Abstract][Full Text] [Related]
14. Naloxone-like protective effect of MIF-1 (Pro-Leu-Gly-NH2) on hemorrhagic shock.
Krause W; Nieber K; Ehrlich A; Bienert M; Oehme P
Pharmazie; 1984 May; 39(5):352-3. PubMed ID: 6147863
[No Abstract] [Full Text] [Related]
15. [Addison disease during pregnancy--a diagnostic dilemma. Symptoms are similar to normal pregnancy problems].
Wålinder O
Lakartidningen; 2005 Jun 27-Jul 10; 102(26-27):1988-90. PubMed ID: 16044755
[TBL] [Abstract][Full Text] [Related]
16. Comparison of in vivo and in vitro corticotropin-releasing hormone-stimulated release of proopiomelanocortin-derived peptides in cats.
Willemse T; Mol JA
Am J Vet Res; 1994 Dec; 55(12):1677-81. PubMed ID: 7887510
[TBL] [Abstract][Full Text] [Related]
17. [Evolution of the adaptive functions of hypophyseal hormones detected by using hypothalamic melanostatin].
Mel'nik BE; Robu AI; Paladiĭ ES
Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (6):41-4. PubMed ID: 6136302
[TBL] [Abstract][Full Text] [Related]
18. Structural specificity of MIF-1 and Tyr-MIF-1 in augmenting GABA-stimulated benzodiazepine receptor binding.
Miller LG; Kastin AJ; Roy RB; Gaver A; Fischman AJ; Horvath A
Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):365-8. PubMed ID: 2908009
[TBL] [Abstract][Full Text] [Related]
19. Structure activity relationship studies with hypothalamic peptide hormones III. Effect of melanotropin-release inhibiting factor and analogs on tolerance to morphine in the rat.
Bhargava HN; Kim HS
Neuropharmacology; 1982 Sep; 21(9):917-22. PubMed ID: 6128692
[TBL] [Abstract][Full Text] [Related]
20. Loperamide, an opiate analogue, inhibits plasma ACTH levels in patients with Addison's disease.
Ambrosi B; Bochicchio D; Faglia G
Clin Endocrinol (Oxf); 1986 May; 24(5):483-9. PubMed ID: 3024866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
